|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments: | |||||
| Depreciation of property and equipment | |||||
| Stock-based compensation expense | |||||
| Deferred income taxes | |||||
| Loss (gain) on debt and equity securities, net | |||||
| Other | |||||
| Changes in assets and liabilities, net of effects of acquisitions: | |||||
| Accounts receivable, net | |||||
| Income taxes, net | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Accrued revenue share | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Purchases of property and equipment | |||||
| Purchases of marketable securities | |||||
| Maturities and sales of marketable securities | |||||
| Purchases of non-marketable securities | |||||
| Maturities and sales of non-marketable securities | |||||
| Acquisitions, net of cash acquired, and purchases of intangible assets | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Net payments related to stock-based award activities | |||||
| Repurchases of stock | |||||
| Dividend payments | |||||
| Proceeds from issuance of debt, net of costs | |||||
| Repayments of debt | |||||
| Proceeds from sale of interest in consolidated entities, net | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Cash paid for income taxes, net of refunds | |||||
| Supplemental disclosures of non-cash investing activities: | |||||
| Purchases of property and equipment included in accrued liabilities and accounts payable | |||||
Loading...